ft 23 jul 92 survey pharmaceut 4 ideal eyewash ec singl market idealist rhetor complet intern market pharmaceut seduc european court justic week ago overrul plea ec commiss set asid 25 year commun harmonis rule nation author decid whether product medicin one ironi occasion enliven ec wrangl product question eyewash case anoth demonstr despit impress progress particularli harmonis requir test product product inform increas patent protect still import gap singl market programm pharmaceut prioriti commiss admit intern creation better european authoris system action area price social secur coverag medicin medicin manufactur agre associ british pharmaceut industri say member prosper research capac depend get european agreement new authoris system appropri mean ensur fair price paid innov medicin last month market authoris solut came closer polit agreement among member state set new european medicin agenc make bind european decis one signific remain impedi free circul could disappear 1994 price reimburs outlook confus larg distinct object differ player member state focu mainli health budget within drug bill mere one element complex nation balanc mani polit factor research base industri want free market condit say allow compet us japanes rival intervent type denounc lead inevit market distort mr alberto aleotti menarini chief execut offic gener medicin manufactur stung patent term extens call compensatori measur ensur signific presenc gener medicin european market european consum repres mr luc joossen complain ec legisl pharmaceut alreadi excess favour industri term recent patent term extens measur catastroph consum long stand critic compani price polici say noth resolv commiss roll price propos autumn probabl stop well short intervention fashion subsidiar sensit brussel like instead updat exist ec transpar requir design prevent abus make member state come clean mechan use control price profit reimburs leav industri much onu polic industri voic favour hand ec approach basi wrong sort ec pressur converg could make thing wors everywher commun flatten revenu overal approach still carri risk industri ec commiss non intervention loudli acclaim german drug industri ceremoni visit european parliament june plenari session strasbourg day later german govern announc decis impos sever cut pharmaceut spend begin year event intern market pharmaceut go introduc predestin pharmaceut provis commiss give greater emphasi market public pronounc continu divers nation health care system habit put premium initi adapt resili say mr igor landau head franc biggest drug compani rhone poulenc sant better price new product even tradit lower price countri say firm keep pressur demonstr product cost effect oper develop strength maximis singl market benefit glaxo say deriv gener advantag establish virtual everi ec member state mr didier wold pari base consult industri predict european pharmaceut market still maze 1993 find right path go becom import ever us drug industri associ offic brussel three year mr michael calingaert european director believ american compani advantag alreadi comfort singl market context even mainlin wholesal catalys prospect singl market internationalis object becom big enough drive better bargain past multin manufactur warn mr mike watt british associ pharmaceut wholesal non prescript medicin sector see new opportun call valid product singl market rule advertis product categori inform accord dr hubertu kranz aesgp parallel import flourish new respect among economi consciou govern look forward sustain growth continu offici support despit outrag manufactur mr david godfrey wellcom observ could market situat distort ec commiss counten say parallel import product account one five brand nh prescript dispens retail pharmacist third past year winner trader best exploit system shop member state repress price system mr paul de souter chairman belgian drug industri associ agim say gloomili singl market bring increas parallel import tougher wholes deal gener substitut could prove high price small addit patent protect possibl drug registr agenc ec commiss mr fernand sauer one chief architect ec drug regul dismiss industri concern parallel import problem past say amount 2 per cent total ec medicin market compani alreadi learnt deal instead mr sauer emphasis opportun see compani build futur free circul allow compani rationalis ec oper harmonis drug test requir permit reduc develop cost increas transpar disclos abus member state practic price reimburs insist player decid whether use opportun certainli go singl market say firm subsector benefit time get wrong could victim intern market success europ whole free eyewash certain clariti vision vital determin player abil see ideal achiev